摘要
目的探讨三联疗法联合康复新液治疗幽门螺杆菌（Hp）相关性溃疡的临床效果。方法选取2013年4月至2015年4月Hp相关性溃疡患者80例，将其分成观察组和对照组，每组40例。两组均采用三联疗法治疗，观察组加用康复新液，比较两组治疗效果。结果观察组幽门螺杆菌根除率[92．5％（37／40）]高于对照组[75．0％（30／40）]，差异有统计学意义（P〈0．05）。观察组总有效率（95．0％）高于对照组（87．5％），差异有统计学意义（t9〈0．05）。结论康复新液联合三联疗法治疗Hp相关性溃疡疗效确切，安全可靠，值得临床推广应用。
Objective To investigate the effect of triple therapy combined with kangfuxin liquid on Helicobacter pylori related peptic ulcer. Methods From April 2013 to April 2015, 80 patients with Helicobacter pylori related peptic ulcer were selected, and they were divided into observation group and control group, with 40 cases in each group. Both groups were given triple therapy, and the observation group combined with kangfuxin liquid, the effects of the two groups were compared. Results Pylori eradicationrates in the observation group was higher than that in the control group 192.5 % （ 37/40 ） vs 75.0% （30/40）1, the difference was significant （P 〈 0.05 ）. Total effective rate in the observation group was 95.0%, which was higher than that in the the control group（87.5% ）, the difference was sig- nificant （P 〈 0.05 ）. Conclusions Kangfuxin liquid combined with triple therapy on Helicobacter pylori related peptic ulcer is safe and reliable, so it is worth spreading.
出处
《中国实用医刊》
2016年第21期42-43,共2页
Chinese Journal of Practical Medicine
关键词
幽门螺杆菌
三联疗法
消化性溃疡
康复新液
Helicobaeter pylori
Triple therapy
Peptic ulcer
Kangfuxin liquid
